Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
International Journal of Obesity
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
November 2001, Volume 25, Number 11, Pages 1615-1618
Table of contents    Previous  Abstract  Next   Full text  PDF
Paper
Downregulation of uncoupling protein 2 mRNA in women treated with glucocorticoids
J Uddén1, R Folkesson2 and J Hoffstedt1

1Centre for Metabolism and Endocrinology, Department of Medicine and Neurotec, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden

2Department of Experimental Geriatrics, Karolinska Institutet of Huddinge University Hospital, Stockholm, Sweden

Correspondence to: J Hoffstedt, Karolinska Institutet, M61, CME, Huddinge University Hospital, S-141 86 Stockholm, Sweden. E-mail: johan.hoffstedt@medhs.ki.se

Abstract

OBJECTIVE: Glucocorticoids are well-known regulators of energy turnover and adipose tissue metabolism. We investigated the effect of glucocorticoids on the expression of the human uncoupling protein 2 (UCP 2) gene, which has been implicated in energy expenditure.

DESIGN: Prednisolone (25 mg) was administered orally daily for 7 days. Subcutaneous adipose tissue UCP 2 mRNA was measured before and after treatment.

SUBJECTS: Eight healthy female subjects (age 52-63 y; body mass index 25-34 kg/m2).

RESULTS: No differences in body weight, waist-to-hip ratio or plasma-values of FFA or glucose were found after prednisolone treatment, as compared to pre-treatment values under these conditions. In contrast, plasma insulin levels were significantly increased by glucocorticoid administration, 54±6 before vs 70±12 (mean±sem) pmol/l after treatment (P=0.028). Furthermore, using RT-competitive-PCR, the UCP 2 mRNA level in abdominal subcutaneous adipose tissue was found to be down-regulated by half (6.3±0.4 vs 3.1±0.8 amol/µg RNA, P=0.012) after glucocorticoid treatment. No difference in expression levels of the reference gene 18SrRNA was observed before, as compared to after prednisolone exposure (249±11 vs 248±30 amol/µg RNA, P=0.87).

CONCLUSION: These data suggest that glucocorticoids may play a role in the regulation of UCP 2 mRNA expression in human adipose tissue in vivo.

International Journal of Obesity (2001) 25, 1615-1618

Keywords

adipose tissue; cortisol; human; insulin

Received 19 January 2000; revised 18 April 2001; accepted 1 May 2001
November 2001, Volume 25, Number 11, Pages 1615-1618
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 2001 Nature Publishing Group